Home LiteratureArticle Details
PMID: 21103374 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice.

PloS one ·Vol. 5 ·No. 11 ·2010-11-16 ·Pages e14005

Gao X, Shin YH, Li M, Wang F, Tong Q, Zhang P

Abstract

FTO (fat mass and obesity associated) was identified as an obesity-susceptibility gene by several independent large-scale genome association studies. A cluster of SNPs (single nucleotide polymorphism) located in the first intron of FTO was found to be significantly associated with obesity-related traits, such as body mass index, hip circumference, and body weight. FTO encodes a protein with a novel C-terminal α-helical domain and an N-terminal double-strand β-helix domain which is conserved in Fe(II) and 2-oxoglutarate-dependent oxygenase family. In vitro, FTO protein can demethylate single-stranded DNA or RNA with a preference for 3-methylthymine or 3-methyluracil. Its physiological substrates and function, however, remain to be defined. Here we report the generation and analysis of mice carrying a conditional deletion allele of Fto. Our results demonstrate that Fto plays an essential role in postnatal growth. The mice lacking Fto completely display immediate postnatal growth retardation with shorter body length, lower body weight, and lower bone mineral density than control mice, but their body compositions are relatively normal. Consistent with the growth retardation, the Fto mutant mice have reduced serum levels of IGF-1. Moreover, despite the ubiquitous expression of Fto, its specific deletion in the nervous system results in similar phenotypes as the whole body deletion, indicating that Fto functions in the central nerve system to regulate postnatal growth.

MeSH Terms
Alpha-Ketoglutarate-Dependent Dioxygenase FTO Animals Blotting, Western Body Weight/genetics,physiology Bone Density/physiology Brain/growth & development,metabolism Dietary Fats/administration & dosage Female Gene Expression Regulation, Developmental Genetic Predisposition to Disease Growth Disorders/genetics,metabolism,physiopathology Male Mice Mice, Inbred C57BL Mice, Knockout Obesity/etiology,genetics,physiopathology Proteins/genetics,metabolism,physiology Reverse Transcriptase Polymerase Chain Reaction
Chemicals
Dietary Fats Proteins FTO protein, mouse Alpha-Ketoglutarate-Dependent Dioxygenase FTO
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Gao Xue
Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Shin Yong-Hyun
Li Min
Wang Fei
Tong Qiang
Zhang Pumin
References (49)
49 references, click to expand
  1. Lack of association of fatness-related FTO gene variants with energy expenditure or physical activity.
    J Clin Endocrinol Metab. 2008 Jul;93(7):2904-8 PMID: 18445669
  2. The FTO gene is associated with adulthood obesity in the Mexican population.
    Obesity (Silver Spring). 2008 Oct;16(10):2296-301 PMID: 18719664
  3. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO.
    FEBS Lett. 2008 Oct 15;582(23-24):3313-9 PMID: 18775698
  4. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans.
    Diabetologia. 2008 Apr;51(4):641-7 PMID: 18251005
  5. Replication of genetic effects of FTO polymorphisms on BMI in a Korean population.
    Obesity (Silver Spring). 2008 Sep;16(9):2187-9 PMID: 18551112
  6. FTO polymorphisms in oceanic populations.
    J Hum Genet. 2007;52(12):1031-1035 PMID: 17928949
  7. Replication of the association of common rs9939609 variant of FTO with increased BMI in an Australian adult twin population but no evidence for gene by environment (G x E) interaction.
    Int J Obes (Lond). 2009 Jan;33(1):75-9 PMID: 19030008
  8. A common variant in the FTO gene is associated with obesity in the Uyghur population.
    J Endocrinol Invest. 2008 Nov;31(11):1043 PMID: 19169064
  9. Prevalence of loss-of-function FTO mutations in lean and obese individuals.
    Diabetes. 2010 Jan;59(1):311-8 PMID: 19833892
  10. The FTO gene and measured food intake in children.
    Int J Obes (Lond). 2009 Jan;33(1):42-5 PMID: 18838977
  11. The fat mass- and obesity-associated locus and dietary intake in children.
    Am J Clin Nutr. 2008 Oct;88(4):971-8 PMID: 18842783
  12. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants.
    PLoS One. 2007 Dec 26;2(12):e1361 PMID: 18159244
  13. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.
    PLoS Genet. 2007 Jul;3(7):e115 PMID: 17658951
  14. Genetic control of growth.
    Eur J Endocrinol. 2005 Jan;152(1):11-31 PMID: 15762183
  15. Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations.
    Am J Hum Genet. 2009 Jul;85(1):106-11 PMID: 19559399
  16. An obesity-associated FTO gene variant and increased energy intake in children.
    N Engl J Med. 2008 Dec 11;359(24):2558-66 PMID: 19073975
  17. Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation.
    Mamm Genome. 1999 Oct;10(10):983-6 PMID: 10501967
  18. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
    Science. 2007 May 11;316(5826):889-94 PMID: 17434869
  19. Variation in the FTO gene influences food intake but not energy expenditure.
    Exp Clin Endocrinol Diabetes. 2009 Apr;117(4):194-7 PMID: 19053021
  20. Direct reversal of DNA alkylation damage.
    Chem Rev. 2006 Feb;106(2):215-32 PMID: 16464003
  21. The FTO gene and obesity in a large Eastern European population sample: the HAPIEE study.
    Obesity (Silver Spring). 2008 Dec;16(12):2764-6 PMID: 18833210
  22. FTO effect on energy demand versus food intake.
    Nature. 2010 Apr 1;464(7289):E1; discussion E2 PMID: 20360686
  23. Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function.
    Genesis. 2000 Feb;26(2):113-5 PMID: 10686601
  24. Obesity associated genetic variation in FTO is associated with diminished satiety.
    J Clin Endocrinol Metab. 2008 Sep;93(9):3640-3 PMID: 18583465
  25. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure.
    Obesity (Silver Spring). 2008 Aug;16(8):1961-5 PMID: 18551109
  26. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.
    Science. 2007 Nov 30;318(5855):1469-72 PMID: 17991826
  27. Widespread recombinase expression using FLPeR (flipper) mice.
    Genesis. 2000 Nov-Dec;28(3-4):106-10 PMID: 11105051
  28. Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue.
    Diabetes. 2009 Oct;58(10):2402-8 PMID: 19587359
  29. The FTO (fat mass and obesity associated) gene codes for a novel member of the non-heme dioxygenase superfamily.
    BMC Biochem. 2007 Nov 08;8:23 PMID: 17996046
  30. Variations in the FTO gene are associated with severe obesity in the Japanese.
    J Hum Genet. 2008;53(6):546-553 PMID: 18379722
  31. Inactivation of the Fto gene protects from obesity.
    Nature. 2009 Apr 16;458(7240):894-8 PMID: 19234441
  32. A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity.
    Endocrinology. 2004 May;145(5):2531-41 PMID: 14726450
  33. Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats.
    PLoS One. 2010 Jan 19;5(1):e8771 PMID: 20098739
  34. Variants in the FTO gene are associated with common obesity in the Belgian population.
    Mol Genet Metab. 2008 Apr;93(4):481-4 PMID: 18055244
  35. Crystal structure of the FTO protein reveals basis for its substrate specificity.
    Nature. 2010 Apr 22;464(7292):1205-9 PMID: 20376003
  36. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
    PLoS Genet. 2009 Aug;5(8):e1000599 PMID: 19680540
  37. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.
    Nat Genet. 1999 Sep;23(1):99-103 PMID: 10471508
  38. Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
    Nat Chem Biol. 2007 Mar;3(3):144-53 PMID: 17301803
  39. GH/IGF-I regulation in obesity--mechanisms and practical consequences in children and adults.
    Horm Res Paediatr. 2010;73(3):153-60 PMID: 20197666
  40. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients.
    Obes Surg. 2009 Jan;19(1):87-95 PMID: 18855084
  41. Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults.
    Diabetologia. 2009 Jul;52(7):1334-8 PMID: 19373445
  42. Variation in FTO contributes to childhood obesity and severe adult obesity.
    Nat Genet. 2007 Jun;39(6):724-6 PMID: 17496892
  43. Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain.
    Clin Endocrinol (Oxf). 2009 Mar;70(3):390-3 PMID: 18616701
  44. Expanding chemical biology of 2-oxoglutarate oxygenases.
    Nat Chem Biol. 2008 Mar;4(3):152-6 PMID: 18277970
  45. Critical role of the hypothalamic-pituitary-thyroid axis in bone.
    Bone. 2008 Sep;43(3):418-26 PMID: 18585995
  46. Towards genetic genome projects: genomic library screening and gene-targeting vector construction in a single step.
    Nat Genet. 2002 Jan;30(1):31-9 PMID: 11753384
  47. Common variation in the fat mass and obesity-associated (FTO) gene confers risk of obesity and modulates BMI in the Chinese population.
    Diabetes. 2008 Aug;57(8):2245-52 PMID: 18487448
  48. FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity.
    J Clin Endocrinol Metab. 2009 Apr;94(4):1281-7 PMID: 19158205
  49. Differential removal of insulin-like growth factor binding proteins in rat serum by solvent extraction procedures.
    Experientia. 1994 May 15;50(5):451-5 PMID: 7515010
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2010-11-16
Epub
2010-00-16
Pages
e14005
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC2982835
Subset
IM
Grants
NCI NIH HHS · R01 CA122623 · United States
NCI NIH HHS · R01 CA116097 · United States
NEI NIH HHS · EY019075 · United States
NCI NIH HHS · CA116097 · United States
NCI NIH HHS · CA122623 · United States
NIDDK NIH HHS · P30 DK079638 · United States
NEI NIH HHS · R01 EY019075 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com